EP1262169A3 - Skin anti-ageing composition - Google Patents
Skin anti-ageing composition Download PDFInfo
- Publication number
- EP1262169A3 EP1262169A3 EP02291298A EP02291298A EP1262169A3 EP 1262169 A3 EP1262169 A3 EP 1262169A3 EP 02291298 A EP02291298 A EP 02291298A EP 02291298 A EP02291298 A EP 02291298A EP 1262169 A3 EP1262169 A3 EP 1262169A3
- Authority
- EP
- European Patent Office
- Prior art keywords
- composition
- neuro
- skin anti
- skin
- substance
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid, pantothenic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
- A61K31/728—Hyaluronic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/74—Synthetic polymeric materials
- A61K31/765—Polymers containing oxygen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/67—Piperaceae (Pepper family), e.g. Jamaican pepper or kava
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/81—Solanaceae (Potato family), e.g. tobacco, nightshade, tomato, belladonna, capsicum or jimsonweed
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/046—Tachykinins, e.g. eledoisins, substance P; Related peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/18—Growth factors; Growth regulators
- A61K38/185—Nerve growth factor [NGF]; Brain derived neurotrophic factor [BDNF]; Ciliary neurotrophic factor [CNTF]; Glial derived neurotrophic factor [GDNF]; Neurotrophins, e.g. NT-3
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/2271—Neuropeptide Y
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/2278—Vasoactive intestinal peptide [VIP]; Related peptides (e.g. Exendin)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/2292—Thymosin; Related peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
- A61K8/735—Mucopolysaccharides, e.g. hyaluronic acid; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
Abstract
L'invention a trait à une composition comprenant dans un support approprié au moins une substance active sur la trophicité des nerfs cutanés et/ou un neuro-stimulant et/ou un neuro-activateur et/ou un neuromédiateur.The invention relates to a composition comprising, in a carrier suitable for less an active substance on the trophicity of the skin nerves and / or a neuro-stimulant and / or a neuro-activator and / or a neuromediator.
L'invention a également trait à l'utilisation dans la préparation d'une composition d'au moins une substance active sur la trophicité des nerfs cutanés et/ou un neuro-stimulant et/ou un neuro-activateur et/ou un neuromédiateur, la substance ou la composition étant destinées à maintenir et/ou à augmenter l'épaisseur de la peau, particulièrement de l'épaisseur de l'épiderme.The invention also relates to the use in the preparation of a composition at least one substance active on the trophicity of the cutaneous nerves and / or a neuro-stimulant and / or a neuro-activator and / or a neuromediator, the substance or the composition being intended to maintain and / or increase the thickness of the skin, particularly the thickness of the epidermis.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0106979A FR2825273B1 (en) | 2001-05-29 | 2001-05-29 | COMPOSITION FOR THE TREATMENT OF SKIN SIGNS OF AGING |
FR0106979 | 2001-05-29 |
Publications (3)
Publication Number | Publication Date |
---|---|
EP1262169A2 EP1262169A2 (en) | 2002-12-04 |
EP1262169A3 true EP1262169A3 (en) | 2004-05-06 |
EP1262169B1 EP1262169B1 (en) | 2013-10-02 |
Family
ID=8863713
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP02291298.4A Revoked EP1262169B1 (en) | 2001-05-29 | 2002-05-28 | Skin anti-ageing composition |
Country Status (6)
Country | Link |
---|---|
US (2) | US20030003123A1 (en) |
EP (1) | EP1262169B1 (en) |
JP (4) | JP2002370966A (en) |
CA (1) | CA2389552A1 (en) |
ES (1) | ES2439566T3 (en) |
FR (1) | FR2825273B1 (en) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8288362B2 (en) | 2004-05-07 | 2012-10-16 | S.K. Pharmaceuticals, Inc. | Stabilized glycosaminoglycan preparations and related methods |
EP1746884A4 (en) * | 2004-05-07 | 2010-01-13 | S K Pharmaceuticals Inc | Stabilized hyaluronan preparations and related methods |
JP2006151971A (en) * | 2004-11-05 | 2006-06-15 | Maruishi Pharmaceutical Co Ltd | Insulin-like growth factor-1 secretion promoter |
FR2916977A1 (en) | 2007-06-06 | 2008-12-12 | Engelhard Lyon Sa | STIMULATION OF SYNTHESIS OF MCR1, MCR2 AND μ OPIOID RECEPTORS. |
KR100889460B1 (en) | 2007-11-19 | 2009-03-17 | (주)아모레퍼시픽 | Composition for enhancing melanogenesis in hair containing gdnf, method for enhancing melanogenesis in hair using gdnf, and method for screening hair-melanogenesis enhancer using gdnf expression level |
WO2009085236A2 (en) * | 2007-12-21 | 2009-07-09 | Immuneregen Biosciences, Inc. | Compositions and methods of using substance p. analogs |
IT1394690B1 (en) * | 2008-10-23 | 2012-07-13 | Carli De | METHOD OF DERMOCOSMETIC TREATMENT OF THE SKIN WITH THE APPLICATION OF COMPOSITIONS CONTAINING NGF. |
FR2949672B1 (en) * | 2009-09-10 | 2017-03-31 | Oreal | USE OF NPY1 OR NPY2 RECEPTOR LIGANDS AS REGULATORY AGENTS OF EPIDERMA HOMEOSTASIS |
US20110159125A1 (en) * | 2009-12-29 | 2011-06-30 | Avon Products, Inc. | CGRP Compositions and Uses Thereof |
FR2957259B1 (en) * | 2010-03-12 | 2012-04-27 | Silab Sa | ACTIVE REFINING COSMETIC PRINCIPLE FROM PIPER NIGRUM, COSMETIC COMPOSITIONS INCLUDING THE SAME AND USE THEREOF |
FR3045385B1 (en) * | 2015-12-22 | 2019-12-20 | Jean-Noel Thorel | COSMETIC COMPOSITION COMPRISING NERVE GROWTH FACTOR EXPRESSION INHIBITORS FOR THE TREATMENT OF PSORIASIS, ATOPIC DERMATITIS AND PRURITUS |
CN111182887A (en) * | 2017-06-14 | 2020-05-19 | 株式会社生物解决方案有限公司 | Cosmetic composition comprising substance P for improving skin wrinkles or anti-inflammatory activity |
FR3077731B1 (en) * | 2018-02-13 | 2020-12-25 | Cep | COSMETIC COMPOSITION CONSISTING OF CAPSICUM ANNUUM PEPPER EXTRACT FOR PROTECTION AGAINST BLUE LIGHT |
FR3096263A1 (en) * | 2019-05-24 | 2020-11-27 | L V M H Recherche | Cosmetic use of honey as a protective active ingredient for the skin sensory system |
Citations (25)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0217413A2 (en) * | 1985-10-03 | 1987-04-08 | Chemisches Laboratorium Dr. Kurt Richter GmbH | Cosmetic composition |
EP0236218A1 (en) * | 1986-02-24 | 1987-09-09 | Claude Bonne | Cosmetic compositions containing an extract of Silybum Marianum fruits |
JPS6422809A (en) * | 1987-07-15 | 1989-01-25 | Kanebo Ltd | Skin cosmetic |
EP0444638A2 (en) * | 1990-02-27 | 1991-09-04 | FIDIA S.p.A. | Process for the expression of human nerve growth factor in arthropoda frugiperda cells by infection with recombinant baculovirus |
JPH05310548A (en) * | 1992-05-13 | 1993-11-22 | Taisho Pharmaceut Co Ltd | Skin external preparation |
WO1995013087A1 (en) * | 1993-11-12 | 1995-05-18 | The Schepens Eye Research Institute, Inc. | Therapeutic regulation of abnormal conjunctival goblet cell mucous secretion |
JPH07145033A (en) * | 1992-11-12 | 1995-06-06 | Kose Corp | Cosmetic for prevention of dermal aging |
EP0672420A1 (en) * | 1992-08-26 | 1995-09-20 | Asahi Kasei Kogyo Kabushiki Kaisha | Wound remedy |
US5614489A (en) * | 1995-05-25 | 1997-03-25 | Mohammadi; Fatemeh | Method and composition for treating the skin |
WO1997030690A1 (en) * | 1996-02-23 | 1997-08-28 | Unilever Plc | Skin treatment with salicylic acid esters |
EP0797984A2 (en) * | 1996-03-27 | 1997-10-01 | Shiseido Company Limited | Anti-aging cosmetic composition |
WO1997035560A1 (en) * | 1996-03-28 | 1997-10-02 | The Board Of Trustees Of The University Of Illinois | Materials and methods for making improved echogenic liposome compositions |
RU2092152C1 (en) * | 1992-12-29 | 1997-10-10 | Госконцерн "Биопрепарат" | Face lotion |
JPH1045615A (en) * | 1996-07-31 | 1998-02-17 | Ichimaru Pharcos Co Ltd | Plant extract-containing fibroblast growth promoter |
WO1998025643A2 (en) * | 1996-12-13 | 1998-06-18 | Konrad Wolf | Neuropeptides as modulators for cell differentiation and proliferation |
WO1998048002A1 (en) * | 1997-04-24 | 1998-10-29 | Alessandro Lambiase | Use of nerve growth factor for the storage, culture or treatment of cornea |
WO1999003448A1 (en) * | 1997-07-14 | 1999-01-28 | The Board Of Trustees Of The University Of Illinois | Materials and methods for making improved micelle compositions |
WO1999038536A1 (en) * | 1998-01-29 | 1999-08-05 | Poly-Med Inc. | Absorbable microparticles |
JP2000026301A (en) * | 1998-07-09 | 2000-01-25 | Inamura:Kk | Therapeutic agent for dermatosis |
US6063757A (en) * | 1995-11-29 | 2000-05-16 | Urso; Richard G. | Wound treatment method with nerve growth factor |
EP1000618A1 (en) * | 1998-11-13 | 2000-05-17 | Maruishi Pharmaceutical Co., Ltd. | Topical capsaicin preparation |
WO2000047221A1 (en) * | 1999-02-11 | 2000-08-17 | National Institute Of Immunology | Antiangiogenic drugs |
WO2000047040A1 (en) * | 1999-02-11 | 2000-08-17 | The Schepens Eye Research Institute, Inc. | Growth medium for human corneal endothelial cells |
US6172086B1 (en) * | 1996-11-13 | 2001-01-09 | Vertex Pharmaceuticals Incorporated | Methods and compositions for stimulating neurite growth |
WO2001030375A2 (en) * | 1999-10-29 | 2001-05-03 | Biopharm Gesellschaft Zur Biotechnologischen Entwicklung Von Pharmaka Mbh | Use of gdnf for treating corneal defects |
Family Cites Families (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4582709A (en) * | 1985-02-08 | 1986-04-15 | Warner-Lambert Company | Chewable mineral supplement |
US5091171B2 (en) * | 1986-12-23 | 1997-07-15 | Tristrata Inc | Amphoteric compositions and polymeric forms of alpha hydroxyacids and their therapeutic use |
GB8914905D0 (en) * | 1989-06-29 | 1989-08-23 | Unilever Plc | Cosmetic composition |
IT1247472B (en) * | 1991-05-31 | 1994-12-17 | Fidia Spa | PROCESS FOR THE PREPARATION OF MICROSPHERES CONTAINING BIOLOGICALLY ACTIVE COMPONENTS. |
US5254331A (en) * | 1991-09-12 | 1993-10-19 | Chanel, Inc. | Skin cream composition |
FR2714829B1 (en) * | 1994-01-10 | 1996-02-02 | Oreal | Cosmetic and / or dermatological composition for the treatment of aging containing ceramides, its use. |
FR2715563B1 (en) * | 1994-01-31 | 1996-03-15 | Oreal | Stabilized emulsion, intended to hydrate the skin and its use. |
US5643586A (en) * | 1995-04-27 | 1997-07-01 | Perricone; Nicholas V. | Topical compositions and methods for treatment of skin damage and aging using catecholamines and related compounds |
JP3542665B2 (en) * | 1995-07-07 | 2004-07-14 | 株式会社資生堂 | Anti-aging skin external preparation, collagen cross-linking inhibition skin external preparation and anti-ultraviolet skin external preparation |
DE19537297A1 (en) * | 1995-07-07 | 1997-01-09 | Paerson & Co Gmbh & Co | Cosmetic, esp. skin or hair care prods. opt. stabilised with heparin and/or chondroitin sulphate - comprise growth factor prepd. directly from milk and colostrum from cows or mares, opt. in soya and/or protein phospholipid liposome form |
US5888522A (en) * | 1996-08-23 | 1999-03-30 | Skin Biology, Inc. | Tissue protective and regenerative compositions |
JPH10120558A (en) * | 1996-10-18 | 1998-05-12 | Dokutaazu Kosumeteikusu:Kk | Skin preparation for improving sputum for external use |
US5863943A (en) * | 1997-06-03 | 1999-01-26 | The Andrew Jergens Company | Stabilized skin conditioner with alpha hydroxy acids |
-
2001
- 2001-05-29 FR FR0106979A patent/FR2825273B1/en not_active Expired - Fee Related
-
2002
- 2002-05-28 CA CA002389552A patent/CA2389552A1/en not_active Abandoned
- 2002-05-28 EP EP02291298.4A patent/EP1262169B1/en not_active Revoked
- 2002-05-28 ES ES02291298.4T patent/ES2439566T3/en not_active Expired - Lifetime
- 2002-05-29 US US10/156,130 patent/US20030003123A1/en not_active Abandoned
- 2002-05-29 JP JP2002156493A patent/JP2002370966A/en not_active Withdrawn
-
2005
- 2005-08-24 JP JP2005242166A patent/JP2005330295A/en not_active Withdrawn
-
2006
- 2006-05-16 US US11/434,207 patent/US20060204471A1/en not_active Abandoned
-
2008
- 2008-04-17 JP JP2008108367A patent/JP2008195734A/en not_active Withdrawn
-
2012
- 2012-09-24 JP JP2012209431A patent/JP2013063972A/en active Pending
Patent Citations (25)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0217413A2 (en) * | 1985-10-03 | 1987-04-08 | Chemisches Laboratorium Dr. Kurt Richter GmbH | Cosmetic composition |
EP0236218A1 (en) * | 1986-02-24 | 1987-09-09 | Claude Bonne | Cosmetic compositions containing an extract of Silybum Marianum fruits |
JPS6422809A (en) * | 1987-07-15 | 1989-01-25 | Kanebo Ltd | Skin cosmetic |
EP0444638A2 (en) * | 1990-02-27 | 1991-09-04 | FIDIA S.p.A. | Process for the expression of human nerve growth factor in arthropoda frugiperda cells by infection with recombinant baculovirus |
JPH05310548A (en) * | 1992-05-13 | 1993-11-22 | Taisho Pharmaceut Co Ltd | Skin external preparation |
EP0672420A1 (en) * | 1992-08-26 | 1995-09-20 | Asahi Kasei Kogyo Kabushiki Kaisha | Wound remedy |
JPH07145033A (en) * | 1992-11-12 | 1995-06-06 | Kose Corp | Cosmetic for prevention of dermal aging |
RU2092152C1 (en) * | 1992-12-29 | 1997-10-10 | Госконцерн "Биопрепарат" | Face lotion |
WO1995013087A1 (en) * | 1993-11-12 | 1995-05-18 | The Schepens Eye Research Institute, Inc. | Therapeutic regulation of abnormal conjunctival goblet cell mucous secretion |
US5614489A (en) * | 1995-05-25 | 1997-03-25 | Mohammadi; Fatemeh | Method and composition for treating the skin |
US6063757A (en) * | 1995-11-29 | 2000-05-16 | Urso; Richard G. | Wound treatment method with nerve growth factor |
WO1997030690A1 (en) * | 1996-02-23 | 1997-08-28 | Unilever Plc | Skin treatment with salicylic acid esters |
EP0797984A2 (en) * | 1996-03-27 | 1997-10-01 | Shiseido Company Limited | Anti-aging cosmetic composition |
WO1997035560A1 (en) * | 1996-03-28 | 1997-10-02 | The Board Of Trustees Of The University Of Illinois | Materials and methods for making improved echogenic liposome compositions |
JPH1045615A (en) * | 1996-07-31 | 1998-02-17 | Ichimaru Pharcos Co Ltd | Plant extract-containing fibroblast growth promoter |
US6172086B1 (en) * | 1996-11-13 | 2001-01-09 | Vertex Pharmaceuticals Incorporated | Methods and compositions for stimulating neurite growth |
WO1998025643A2 (en) * | 1996-12-13 | 1998-06-18 | Konrad Wolf | Neuropeptides as modulators for cell differentiation and proliferation |
WO1998048002A1 (en) * | 1997-04-24 | 1998-10-29 | Alessandro Lambiase | Use of nerve growth factor for the storage, culture or treatment of cornea |
WO1999003448A1 (en) * | 1997-07-14 | 1999-01-28 | The Board Of Trustees Of The University Of Illinois | Materials and methods for making improved micelle compositions |
WO1999038536A1 (en) * | 1998-01-29 | 1999-08-05 | Poly-Med Inc. | Absorbable microparticles |
JP2000026301A (en) * | 1998-07-09 | 2000-01-25 | Inamura:Kk | Therapeutic agent for dermatosis |
EP1000618A1 (en) * | 1998-11-13 | 2000-05-17 | Maruishi Pharmaceutical Co., Ltd. | Topical capsaicin preparation |
WO2000047221A1 (en) * | 1999-02-11 | 2000-08-17 | National Institute Of Immunology | Antiangiogenic drugs |
WO2000047040A1 (en) * | 1999-02-11 | 2000-08-17 | The Schepens Eye Research Institute, Inc. | Growth medium for human corneal endothelial cells |
WO2001030375A2 (en) * | 1999-10-29 | 2001-05-03 | Biopharm Gesellschaft Zur Biotechnologischen Entwicklung Von Pharmaka Mbh | Use of gdnf for treating corneal defects |
Non-Patent Citations (6)
Title |
---|
DATABASE WPI Week 198910, Derwent World Patents Index; AN 1989-071645, XP002272686 * |
DATABASE WPI Week 199401, Derwent World Patents Index; AN 1994-002221, XP002272687 * |
DATABASE WPI Week 199531, Derwent World Patents Index; AN 1995-237128, XP002272690 * |
DATABASE WPI Week 199817, Derwent World Patents Index; AN 1998-189185, XP002272689 * |
DATABASE WPI Week 199822, Derwent World Patents Index; AN 1998-249300, XP002272688 * |
DATABASE WPI Week 200016, Derwent World Patents Index; AN 2000-176892, XP002272691 * |
Also Published As
Publication number | Publication date |
---|---|
ES2439566T3 (en) | 2014-01-23 |
FR2825273B1 (en) | 2006-11-24 |
JP2008195734A (en) | 2008-08-28 |
JP2013063972A (en) | 2013-04-11 |
JP2005330295A (en) | 2005-12-02 |
FR2825273A1 (en) | 2002-12-06 |
US20030003123A1 (en) | 2003-01-02 |
JP2002370966A (en) | 2002-12-24 |
CA2389552A1 (en) | 2002-11-29 |
EP1262169A2 (en) | 2002-12-04 |
EP1262169B1 (en) | 2013-10-02 |
US20060204471A1 (en) | 2006-09-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP1262169A3 (en) | Skin anti-ageing composition | |
FR2779643B1 (en) | COSMETIC COMPOSITION COMPRISING AT LEAST ONE ADHESIVE POLYMER AND AT LEAST ONE FIXING POLYMER | |
BR0316000A (en) | Polyamino and / or polyammonium polysiloxane linear copolymers | |
IT1293690B1 (en) | ANGIOPLASTIC STENT, PARTICULARLY FOR THE TREATMENT OF AORTO-HOSPITAL AND HOSPITAL INJURIES. | |
DE69826957D1 (en) | Combined bipolar scissors and gripping instrument | |
BR9913517A (en) | Composition, device, and, use of a composition | |
AU4372199A (en) | Electrochemical based assay processes, instrument and labels | |
FR2825277B1 (en) | COSMETIC AND / OR DERMATOLOGICAL AND / OR PHARMACEUTICAL COMPOSITION CONTAINING AT LEAST ONE ENZIME 3, B-HSD IHNIBITOR COMPOUND | |
WO2004045572A8 (en) | Compositions for treating infected skin and mucous membrane comprising an anti-microbial agent and an essential oil | |
DE69914402D1 (en) | Energy-curable, hydrophilic and pressure-sensitive adhesive composition and its use | |
AU2307999A (en) | Muscarinic agents and use thereof to treat glaucoma, myopia and various other conditions | |
FR2856294B1 (en) | COSMETIC USE OF A COMPOSITION COMPRISING AT LEAST ONE OXAZOLIN AS AN ACTIVE INGREDIENT, AS SLIMMING AND / OR FOR PREVENTING AND / OR TREATING CELLULITE | |
AU2206699A (en) | Muscarinic agents and use thereof to treat glaucoma, myopia and various other conditions | |
DE69824502D1 (en) | Energy-curable, hydrophilic and pressure-sensitive adhesive composition and its use | |
FR2719768B1 (en) | Use of extracts of filamentous bacteria as cosmetic agents against skin aging. | |
CA2348801A1 (en) | Device for applying a cosmetic or care product onto keratin fibres, such as eyelashes or eyebrows | |
FR2801204B1 (en) | COSMETIC COMPOSITION COMPRISING AT LEAST ONE FILM-FORMING POLYMER AND AT LEAST ONE REGULATING AGENT | |
ITRM970731A0 (en) | COMPOSITION FOR THE TREATMENT OF BURNS, SUN RYTHEMAS, ABRASIONS, SORES AND SKIN IRRITATIONS | |
IT1304008B1 (en) | DEVICE FOR THE ELIMINATION OF RATS AND SIMILAR. | |
AU2002366451A1 (en) | Emulsified skin care composition containing salicylic acid, lanolin oil, and propylene glycol | |
BR0002546A (en) | Topical cosmetic agent containing bezaldoximas | |
WO2003017966A3 (en) | Use of luffa cylindrica oil in cosmetic and dermopharmaceutical compositions | |
WO1999060989A3 (en) | Preparation for treating human skin and human hair comprising a special active ingredient combination, and the use of this active ingredient combination | |
BR9506389B1 (en) | silicon, and dietary, cosmetic and therapeutic composition. | |
FR2801201B1 (en) | HIGH-RESISTANCE COSMETIC COMPOSITION COMPRISING AT LEAST ONE FILM-FORMING POLYMER |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
AK | Designated contracting states |
Kind code of ref document: A2 Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR |
|
AX | Request for extension of the european patent |
Free format text: AL;LT;LV;MK;RO;SI |
|
PUAL | Search report despatched |
Free format text: ORIGINAL CODE: 0009013 |
|
RIC1 | Information provided on ipc code assigned before grant |
Ipc: 7A 61K 35/78 B Ipc: 7A 61K 31/765 B Ipc: 7A 61K 31/728 B Ipc: 7A 61K 31/726 B Ipc: 7A 61K 31/14 B Ipc: 7A 61K 38/17 B Ipc: 7A 61K 38/18 B Ipc: 7A 61K 7/48 A |
|
AK | Designated contracting states |
Kind code of ref document: A3 Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR |
|
AX | Request for extension of the european patent |
Extension state: AL LT LV MK RO SI |
|
17P | Request for examination filed |
Effective date: 20041108 |
|
AKX | Designation fees paid |
Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR |
|
17Q | First examination report despatched |
Effective date: 20050214 |
|
GRAP | Despatch of communication of intention to grant a patent |
Free format text: ORIGINAL CODE: EPIDOSNIGR1 |
|
RIC1 | Information provided on ipc code assigned before grant |
Ipc: A61K 8/97 20060101ALI20130116BHEP Ipc: A61Q 19/08 20060101ALI20130116BHEP Ipc: A61K 8/64 20060101ALI20130116BHEP Ipc: A61K 8/34 20060101ALI20130116BHEP Ipc: A61K 8/73 20060101AFI20130116BHEP Ipc: A61K 38/18 20060101ALI20130116BHEP |
|
REG | Reference to a national code |
Ref country code: DE Ref legal event code: R079 Ref document number: 60245602 Country of ref document: DE Free format text: PREVIOUS MAIN CLASS: A61K0007480000 Ipc: A61K0008730000 |
|
GRAP | Despatch of communication of intention to grant a patent |
Free format text: ORIGINAL CODE: EPIDOSNIGR1 |
|
RIC1 | Information provided on ipc code assigned before grant |
Ipc: A61K 31/726 20060101ALI20130610BHEP Ipc: A61K 8/97 20060101ALI20130610BHEP Ipc: A61K 36/81 20060101ALI20130610BHEP Ipc: A61K 31/00 20060101ALI20130610BHEP Ipc: A61K 31/197 20060101ALI20130610BHEP Ipc: A61K 31/765 20060101ALI20130610BHEP Ipc: A61K 8/34 20060101ALI20130610BHEP Ipc: A61Q 19/08 20060101ALI20130610BHEP Ipc: A61K 8/73 20060101AFI20130610BHEP Ipc: A61K 31/165 20060101ALI20130610BHEP Ipc: A61K 38/22 20060101ALI20130610BHEP Ipc: A61K 36/67 20060101ALI20130610BHEP Ipc: A61K 38/04 20060101ALI20130610BHEP Ipc: A61K 31/728 20060101ALI20130610BHEP Ipc: A61K 38/18 20060101ALI20130610BHEP Ipc: A61K 8/64 20060101ALI20130610BHEP Ipc: A61K 36/00 20060101ALI20130610BHEP |
|
INTG | Intention to grant announced |
Effective date: 20130701 |
|
GRAS | Grant fee paid |
Free format text: ORIGINAL CODE: EPIDOSNIGR3 |
|
GRAA | (expected) grant |
Free format text: ORIGINAL CODE: 0009210 |
|
AK | Designated contracting states |
Kind code of ref document: B1 Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR |
|
REG | Reference to a national code |
Ref country code: GB Ref legal event code: FG4D Free format text: NOT ENGLISH |
|
REG | Reference to a national code |
Ref country code: AT Ref legal event code: REF Ref document number: 634252 Country of ref document: AT Kind code of ref document: T Effective date: 20131015 Ref country code: CH Ref legal event code: EP |
|
REG | Reference to a national code |
Ref country code: IE Ref legal event code: FG4D Free format text: LANGUAGE OF EP DOCUMENT: FRENCH |
|
REG | Reference to a national code |
Ref country code: DE Ref legal event code: R096 Ref document number: 60245602 Country of ref document: DE Effective date: 20131128 |
|
REG | Reference to a national code |
Ref country code: ES Ref legal event code: FG2A Ref document number: 2439566 Country of ref document: ES Kind code of ref document: T3 Effective date: 20140123 |
|
REG | Reference to a national code |
Ref country code: AT Ref legal event code: MK05 Ref document number: 634252 Country of ref document: AT Kind code of ref document: T Effective date: 20131002 |
|
REG | Reference to a national code |
Ref country code: NL Ref legal event code: VDEP Effective date: 20131002 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: FI Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20131002 Ref country code: NL Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20131002 Ref country code: SE Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20131002 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: AT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20131002 Ref country code: CY Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20131002 |
|
PLBI | Opposition filed |
Free format text: ORIGINAL CODE: 0009260 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: PT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20140203 |
|
26 | Opposition filed |
Opponent name: HENKEL AG & CO. KGAA Effective date: 20140625 |
|
PLAX | Notice of opposition and request to file observation + time limit sent |
Free format text: ORIGINAL CODE: EPIDOSNOBS2 |
|
REG | Reference to a national code |
Ref country code: DE Ref legal event code: R026 Ref document number: 60245602 Country of ref document: DE Effective date: 20140625 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: DK Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20131002 |
|
REG | Reference to a national code |
Ref country code: DE Ref legal event code: R119 Ref document number: 60245602 Country of ref document: DE |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: LU Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20140528 |
|
REG | Reference to a national code |
Ref country code: CH Ref legal event code: PL |
|
PLAF | Information modified related to communication of a notice of opposition and request to file observations + time limit |
Free format text: ORIGINAL CODE: EPIDOSCOBS2 |
|
GBPC | Gb: european patent ceased through non-payment of renewal fee |
Effective date: 20140528 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: MC Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20131002 Ref country code: LI Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20140531 Ref country code: CH Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20140531 |
|
REG | Reference to a national code |
Ref country code: IE Ref legal event code: MM4A |
|
REG | Reference to a national code |
Ref country code: DE Ref legal event code: R119 Ref document number: 60245602 Country of ref document: DE Effective date: 20141202 |
|
REG | Reference to a national code |
Ref country code: FR Ref legal event code: ST Effective date: 20150130 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: IT Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20140528 Ref country code: IE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20140528 Ref country code: DE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20141202 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: FR Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20140602 Ref country code: GB Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20140528 |
|
REG | Reference to a national code |
Ref country code: ES Ref legal event code: FD2A Effective date: 20150630 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: ES Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20140529 |
|
RDAF | Communication despatched that patent is revoked |
Free format text: ORIGINAL CODE: EPIDOSNREV1 |
|
RDAG | Patent revoked |
Free format text: ORIGINAL CODE: 0009271 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: PATENT REVOKED |
|
27W | Patent revoked |
Effective date: 20150925 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: GR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20140103 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: BE Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20140531 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: TR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20131002 |